fbpx

Michael Burry vs Institutional Outlook

Your capital is at risk if you invest. You could lose all your investment. Please see the full risk warning here.

Many investors would be aware of the name “Michael Burry”. An eccentric doctor-turned-trader, Michael Burry shot to fame after correctly predicting the 2008 subprime mortgage crisis that triggered the Great Recession. His decision to short the subprime market made him and his investors around $100 million and $700 million in profits respectively. He was made even more famous after being featured in Michael Lewis’ book “The Big Short”, which was then adapted into a blockbuster Hollywood movie with Christian Bale assaying his character. Since then, he’s become an online celebrity of sorts prone to posting (and then scrubbing) extremely terse comments on Twitter under the username “Cassandra B.C.”. The username is itself a reference to the Apollo-worshipping Trojan priestess from Greek mythology fated to utter true prophecies but never to be believed. As an investor renowned for making short bets, this appellation might even be considered rather apropos.

Securities filing from last week showed that Dr. Burry has held bearish put options against shares tracking the S&P 500 and Nasdaq 100 indices worth a combined $1.6 billion at the end of the second quarter. However, what news media have often failed to report is that this is the value of the underlying and not the amount spent on buying said options Furthermore, there are no details about the strike price or time to maturity. Dr. Burry’s investment management firm, Scion Asset Management, had a little under $238 million in assets under management (AUM) as of end of Q1 2023.

Furthermore, unlike the Trojan priestess, not every one of Dr. Burry’s predictions have held true.

His most recent major prophecy involved a simple statement of “Sell” made via Twitter in January this year, which didn’t hold true. Dr. Burry later withdrew this tweet. This time, however, his Twitter (now “X”) account is shuttered and the actual act of “skin in the game” was revealed via filings.

There is, of course, some rationale behind Dr. Burry’s decision to be bearish. Several articles in the Year to Date (YTD) have highlighted the fact that all is not well in the global macroeconomic outlook for most of the Developed Market economies, where fundamentals have been rather muddled. Nowhere is this truer than in the U.S. As per a report released by Bank of America a little before Dr. Burry’s filings were made known, the United States government is poised to accrue debt at a rate of a staggering $5.2 billion a day for the next 10 years.

The relative tightness and overdependence on US debt can also be indirectly assessed by US crude oil reserves, including the Strategic Petroleum Reserve, are at lows not seen since 1985 and are even lower after the massive selloff executed in 2021-2022.

With the U.S. Federal Reserve intent on hiking rates, this means that the US government’s share of debt being issued to pay past debt will likely continue to grow. US 30-Year Treasury debt is trading in a “Goldilocks” range, signaling a turnaround to increasing attractiveness relative to US equity markets.

Unsurprisingly, Fitch had downgraded the US in early August citing a steady deterioration in standards of governance over the last 20 years, including on fiscal and debt matters. On the 15th, Fitch also warned it might have to downgrade a slew of US banks including giants like JPMorgan. This was to be expected, given that Moody’s had slashed credit ratings on 10 US banks and 11 other lenders at around the same time.

This has consequences in the private market space as well. “Insurtech” startups and ventures, which had traditionally been highly valued, are estimated to be at 5-year lows with respect to funding as well as a general drop in volumes. “Insurtech” Mergers & Acquisition (M&A) exits have grown 45% Quarter-on-Quarter, almost completely reversing a recent slowdown.

Investors have been shoring up their investments in privately-held growth companies; with early figures at H1 already well past those for the entirety of 2022.

Despite this, Bank of America reports that tech inflows into the tech sector have been seen an increase in the past couple of weeks, despite a general downturn in valuations.

This could be considered to be more along the lines of a “flight to safety” towards large- and mega-cap tech companies who are deemed as being more “survivable” on account of their liquidity. This assertion is borne out by the fact that tech valuations have been declining in the private markets, especially in later-stage investment rounds.

In the tech valuation landscape for Q2, the standout facts that remain are:

  • Median tech valuations dropped again quarter-over-quarter (QoQ) for Series A (-14%), Series C (-9%), and Series D+ (-33%) startups.

  • The later the stage, the sharper the valuation decline year-over-year (YoY) in Q2’23. While the median valuation for seed/angel and Series A rounds fell 15% and 29% YoY, respectively, Series B to Series D+ valuations tumbled between 30% and 60%.

  • Deals negotiated with seniority or tiered liquidation structures gained share across every stage from Series A to Series D+ in H1’23.

  • Over half (60.6%) of Series D+ deals had seniority or tiered liquidation structures in H1’23.

Juxtaposing the two scenarios together brings out a worrying picture: “Big Tech” is expected to be bigger, with very few newcomers (if any) foreseen as being capable of accruing value by outright competition.

Overall, flows into Emerging Markets (EM) equities have been outstripping flows into Developed Markets (DM) economies. The biggest beneficiaries to this have been, of course, Chinese and Indian equities.

However, it bears noting that the flows into Chinese equities are essentially making up for outflows seen during 2022 as geopolitical tensions were ratcheting. The rise in flows towards Indian equities, however, is a new development. Traditionally, a small number of foreign investors have remained resolute in managing their holdings: these new inflows signify growing attention.

Of all types of markets and strategies, European equities and long-only funds come out the worse for wear so far. The latter highlights the adoption of a tactical mindset among institutional investors by cashing in on dip/rise situations. Rising rates have also made bank loans and government bonds increasingly attractive for said investors. The outsized shift away from commodities, in the meantime, is yet another factor indicating that recessionary pressures aren’t off the table. In a recessionary outlook, consumption is expected to dip. Therefore, the commodities outlook turns bearish.

All in all, Bank of America – unlike Dr. Burry – concludes on a “Neutral” signal on its “Bulls & Bears Indicator”, which is an accurate assessment of the state of markets. Tech narratives continue to be shaky, and the consumption outlook will continue to decline (as evidenced by the reports from Disney and Target, among others), while sector rotation is bound to continue to smooth out market concentration, and Emerging Markets — led by India and China — will continue to garner interest.

The rising utilization of tactical trading instruments such as leveraged products by institutional investors to cash in on tactical opportunities and firm up balance sheets should also be borne in mind in the weeks and quarters to come. For professional investors, there is a wealth of Exchange-Traded Products (ETPs) to choose from: SP5Y gives leveraged exposure to the upside of the S&P 500 while SPYS does the same on the downside, QQQ3 gives leveraged exposure to the upside of the Nasdaq-100 while QQ3S does the same on the downside, CHI3 gives a 3X exposure to the upside of the Chinese market while CHNS gives a 3X exposure to the downside, and IND3 gives a 3X daily-rebalanced exposure to the upside of the iShares MSCI India ETF while INDS does the same on the downside.

Your capital is at risk if you invest. You could lose all your investment. Please see the full risk warning here.

Post correlati

Violeta-540x540-1.jpg
Violeta Todorova
Supply, demand disequilibrium and lower US rates could squeeze the non-precious metal
Supply, demand disequilibrium and lower US rates could squeeze the non-precious metal
Violeta-540x540-1.jpg
Boyan Girginov
Supply, demand disequilibrium and lower US rates could squeeze the non-precious metal
Supply, demand disequilibrium and lower US rates could squeeze the non-precious metal
Supply, demand disequilibrium and lower US rates could squeeze the non-precious metal
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Violeta-540x540-1.jpg
Sandeep Rao
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Violeta-540x540-1.jpg
Violeta Todorova
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
What is an ETF? How does an ETF work? Key characteristics of ETFs.
What is an ETF? How does an ETF work? Key characteristics of ETFs.
Violeta-540x540-1.jpg
Boyan Girginov
What is an ETF? How does an ETF work? Key characteristics of ETFs.
What is an ETF? How does an ETF work? Key characteristics of ETFs.
What is an ETF? How does an ETF work? Key characteristics of ETFs.
Violeta-540x540-1.jpg
Pawel Uchman
A quick primer on leveraged instruments available in markets today.
A quick primer on leveraged instruments available in markets today.
Violeta-540x540-1.jpg
Sandeep Rao
A quick primer on leveraged instruments available in markets today.
A quick primer on leveraged instruments available in markets today.
A quick primer on leveraged instruments available in markets today.

Violeta Todorova

Senior Research

Violeta se unió a Leverage Shares en septiembre de 2022. Ella gestiona la realización de análisis técnicos, investigación macroeconómica y de acciones, y ofrece información valiosa que ayuda a la definición de estrategias de inversión para los clientes.

Antes de unirse a LS, Violeta trabajó en varias empresas de inversión de alto perfil en Australia, como Tollhurst y Morgans Financial, donde pasó los últimos 12 años de su carrera.

Violeta es una técnica de mercado certificada de la Asociación Australiana de Analistas Técnicos y tiene un Diploma de Postgrado en Finanzas e Inversiones Aplicadas de Kaplan Professional (FINSIA), Australia, donde fue profesora durante varios años.

Julian Manoilov

Marketing Lead
Julián se unió a Leverage Shares en 2018 como parte de la principal expansión de la compañía en Europa del Este. Él es responsable de diseñar estrategias de marketing y promover el conocimiento de la marca.

Oktay Kavrak

Head of Communications and Strategy

Oktay se incorporó en Laverage Shares a fines de 2019. Él es responsable de impulsar el crecimiento del negocio al mantener relaciones clave y desarrollar la actividad de ventas en los mercados de habla inglesa.

Él vino de UniCredit, donde fue gerente de relaciones corporativas para empresas multinacionales. Su experiencia previa es en finanzas corporativas y administración de fondos en empresas como IBM Bulgaria y DeGiro / FundShare.

Oktay tiene una licenciatura en Finanzas y Contabilidad y un certificado de posgrado en formación empresarial de Babson College. También es titular de una certificado CFA (Chartered Financial Analyst).

Sandeep Rao

Investigación

Sandeep se unió a Leverage Shares en septiembre de 2020. Está a cargo de la investigación de líneas de productos existentes y nuevas, clases de activos y estrategias, con un enfoque particular en el análisis de eventos y desarrollos recientes.

Sandeep tiene una larga experiencia en los mercados financieros. Comenzó en un hedge fund con sede en Chicago como ingeniero financiero, su carrera abarcó varios dominios y organizaciones durante un período de 8 años, desde la División de Prime Services de Barclays Capital hasta (más recientemente) el Equipo Index Research de Nasdaq.

Sandeep tiene una maestría en Finanzas, así como un MBA del Illinois Institute of Technology de Chicago.

Gold Retreats But Rally is Not Over

Copper Ready to Explode

Q2 2024 Market Outlook: Rocky Road Ahead

What is an ETF? (Exchange Traded Fund)

How Do Leverage Shares ETPs Trade in Multiple Currencies

Currency Impact

Build your own ETP Basket
Leverage Shares: Europe’s top leveraged and inverse ETP provider.
Main ETP benefits
Common investor questions

Get the Newsletter

Never miss out on important announcements. Get premium content ahead of the crowd. Enjoy exclusive insights via the newsletter only.